UK markets closed

Avidity Biosciences, Inc. (RNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
26.45+0.87 (+3.40%)
At close: 04:00PM EDT
27.00 +0.55 (+2.08%)
After hours: 07:35PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-212,220
-212,220
-173,995
-118,009
-44,355
Depreciation & amortisation
2,101
2,101
1,387
639
373
Stock-based compensation
38,222
38,222
27,139
17,056
4,310
Change in working capital
61,129
61,129
7,067
4,643
2,332
Accounts payable
1,769
1,769
18,315
6,043
5,749
Other working capital
-123,292
-123,292
-139,091
-98,553
-38,209
Other non-cash items
2,978
2,978
2,749
679
214
Net cash provided by operating activities
-119,064
-119,064
-136,268
-94,813
-37,117
Cash flows from investing activities
Investments in property, plant and equipment
-4,228
-4,228
-2,823
-3,740
-1,092
Purchases of investments
-461,002
-461,002
-355,837
-85,357
-6,693
Sales/maturities of investments
335,160
335,160
168,705
6,580
0
Net cash used for investing activities
-130,070
-130,070
-189,955
-82,517
-7,785
Cash flows from financing activities
Debt repayment
-
-
0
0
-4,683
Common stock issued
60,547
60,547
344,779
174,677
274,054
Dividends paid
-
-
-
0
0
Other financing activities
-
-
-
-11,262
-24,026
Net cash used provided by (used for) financing activities
93,864
93,864
346,171
176,316
272,037
Net change in cash
-155,270
-155,270
19,948
-1,014
227,135
Cash at beginning of period
340,647
340,647
320,699
321,713
94,578
Cash at end of period
185,377
185,377
340,647
320,699
321,713
Free cash flow
Operating cash flow
-119,064
-119,064
-136,268
-94,813
-37,117
Capital expenditure
-4,228
-4,228
-2,823
-3,740
-1,092
Free cash flow
-123,292
-123,292
-139,091
-98,553
-38,209